Arrowhead Prescription drugs Presents New Pivotal Section 3 Information at ESC 2024 from PALISADE Examine of Plozasiran in Sufferers with Familial Chylomicronemia Syndrome
- Plozasiran lowered triglycerides by 80% from baseline and lowered the chance…
